Completed PHASE1 INTERVENTIONAL NCT00259181

A Protocol for the Use of Chlorhexidine Gluconate Saturation for the Reduction of Dental Biofilm Formation on Polymethylmethacrylate Restoration

Examination of the Immersion of Provisional Crown Material in Chlorhexidine Gluconate on Dental Plaque Formation in Vivo

Sponsor: Hadassah Medical Organization

Conditions Dental Plaque

Interventions saturation of polymethylmethacrylate with chlorhexidine gluconate to reduce in vivo plaque formation

Updated 5 times since 2017 Last updated: Jan 5, 2010 Started: Jan 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00259181, this PHASE1 trial focuses on Dental Plaque and remains completed. Sponsored by Hadassah Medical Organization, it has been updated 5 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Jan 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hadassah Medical Organization

Data source: Hadassah Medical Organization

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jerusalem, Israel